136 related articles for article (PubMed ID: 10328487)
1. Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy.
Davin JC; Gruppen M; Bouts AH; Groothoff JW; van Amstel SP; Surachno J; ten Berge IJ; Weening JJ
Nephrol Dial Transplant; 1999 Apr; 14(4):984-7. PubMed ID: 10328487
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome.
Agarwal DK; Gulati S; Mehta A; Kumar A; Sharma RK; Mehta B; Gupta A; Gupta RK
Nephrol Dial Transplant; 2000 Dec; 15(12):2064-5. PubMed ID: 11096161
[No Abstract] [Full Text] [Related]
3. Haemolytic-uraemic syndrome in a renal transplant recipient treated by conversion to mycophenolate mofetil.
McGregor DO; Robson RA; Lynn KL
Nephron; 1998 Nov; 80(3):365-6. PubMed ID: 9807054
[No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
Carl S; Wiesel M
Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil for the transplanted kidney?
Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
[TBL] [Abstract][Full Text] [Related]
6. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
Thervet E
Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
[No Abstract] [Full Text] [Related]
7. Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil.
McKane W; Kanganas C; Preston R; Cairns T; Hakim N; Palmer A; Taube D
Transplant Proc; 2001; 33(1-2):1224-5. PubMed ID: 11267268
[No Abstract] [Full Text] [Related]
8. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
Chenhsu RY; Wu YM; Min DI; Zimmerman MB
Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
[No Abstract] [Full Text] [Related]
9. Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.
Verhave JC; Westra D; van Hamersvelt HW; van Helden M; van de Kar NC; Wetzels JF
Neth J Med; 2013 Sep; 71(7):342-7. PubMed ID: 24038559
[TBL] [Abstract][Full Text] [Related]
10. Haemolytic-uraemic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection.
Schmidt RH; Lenz T; Gröne HJ; Geiger H; Scheuermann EH
Nephrol Dial Transplant; 1999 Apr; 14(4):979-83. PubMed ID: 10328486
[No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil for prevention of acute rejection.
Winearls CG
Lancet; 1995 Jul; 346(8969):253-4. PubMed ID: 7616828
[No Abstract] [Full Text] [Related]
12. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
Rerolle JP; Szelag JC; Le Meur Y
Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
14. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
Pratap B; Abraham G; Srinivas CN; Bhaskar S
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for prevention of acute rejection.
Moore R; Griffin P; Darby C; Jurewicz A; Lord R
Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
[No Abstract] [Full Text] [Related]
16. Mycophenolate mofetil-associated enterocolitis.
Liu TC; Amorosino MS; Cerda S; Farraye FA
Gastrointest Endosc; 2006 Apr; 63(4):707-8, discussion 708. PubMed ID: 16564882
[No Abstract] [Full Text] [Related]
17. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
Friedrich J; Erhard J
Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
[No Abstract] [Full Text] [Related]
18. Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
Elkhammas EA; Yilmaz S; Henry ML; Yenchar J; Bumgardner GL; Pelletier RP; Ferguson RM
Transplant Proc; 1998 Mar; 30(2):512. PubMed ID: 9532152
[No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
Kiehl MG
Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
